J. Kim

Statistics and Probability · Epidemiology and Health · 2005–2022

A researcher in the Science corpus: 3 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom J. Kim trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Douglas G. Altman (in Statistics and Probability)
  2. David Moher (in Statistics and Probability)

Papers from J. Kim's perspective

Ordered by how strongly the researchers J. Kim trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. (Journal of Clinical Oncology)
  2. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (British medical journal)
  3. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review (Medical Journal of Australia)
  4. Reducing waste from incomplete or unusable reports of biomedical research. (The Lancet)
  5. What is missing from descriptions of treatment in trials and reviews? (British medical journal)
  6. Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias (PLoS ONE)
  7. Statistical considerations in the intent-to-treat principle. (Controlled Clinical Trials)
  8. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. (New England Journal of Medicine)
  9. Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates (New England Journal of Medicine)
  10. Optimal medical therapy with or without PCI for stable coronary disease. (New England Journal of Medicine)

Their papers